Cerus Endovascular


Cerus Endovascular is a medical device spin-out, engaged in the design and development of highly differentiated and proprietary interventional neuroradiology (INR) devices and delivery systems. Cerus believes that these devices represent the next generation in the minimally invasive treatment of neurovascular diseases, particularly intracranial aneurysms.

The Company’s first product, e-clipseTM, is an aneurysm occlusive device that simply and safely addresses greater than 70% of the current neurovascular aneurysm procedures attempted by surgical clipping, minimally invasive metal coils and liquid embolics.